128 related articles for article (PubMed ID: 19753738)
1. Time course of PUVA erythema.
Man I; Ibbotson SH
J Dermatolog Treat; 2002 Dec; 13(4):179-83. PubMed ID: 19753738
[TBL] [Abstract][Full Text] [Related]
2. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
[TBL] [Abstract][Full Text] [Related]
3. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
5. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
6. Time course of skin photosensitivity following trimethylpsoralen bath PUVA.
Man I; Wainwright NJ; Gibbs NK; Ferguson J
Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):211-5. PubMed ID: 11068860
[TBL] [Abstract][Full Text] [Related]
7. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
8. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
9. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
[TBL] [Abstract][Full Text] [Related]
10. [Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
Rodríguez-Granados MT; Carrascosa JM; Gárate T; Gómez-Díez S; Guimaraens-Juantorena D
Actas Dermosifiliogr; 2007 Apr; 98(3):164-70. PubMed ID: 17504700
[TBL] [Abstract][Full Text] [Related]
11. Concentration-dependent phototoxicity in trimethylpsoralen bath psoralen ultraviolet A.
Snellman E; Rantanen T
Br J Dermatol; 2001 Mar; 144(3):490-4. PubMed ID: 11260004
[TBL] [Abstract][Full Text] [Related]
12. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
13. Can the immersion time of PUVA bath therapy be shortened?
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Acta Derm Venereol; 2002; 82(1):18-20. PubMed ID: 12013191
[TBL] [Abstract][Full Text] [Related]
14. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
15. The time-course of psoralen ultraviolet A (PUVA) erythema.
Ibbotson SH; Farr PM
J Invest Dermatol; 1999 Sep; 113(3):346-50. PubMed ID: 10469332
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
17. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
18. Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.
Al-Ismail D; Edwards C; Al-Ofi O; Anstey AV
Br J Dermatol; 2013 Sep; 169(3):687-9. PubMed ID: 23607709
[TBL] [Abstract][Full Text] [Related]
19. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
20. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
Speight EL; Farr PM
Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]